(2026). A novel polyester–drug nanoconjugate with subtype selectivity for high efficacy against PSMA-positive prostate cancer. Regenerative Biomaterials.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"A Novel Polyester–drug Nanoconjugate with Subtype Selectivity for High Efficacy Against PSMA-positive Prostate Cancer."
Regenerative Biomaterials 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"A Novel Polyester–drug Nanoconjugate with Subtype Selectivity for High Efficacy Against PSMA-positive Prostate Cancer."
Regenerative Biomaterials, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.